Search clinical trials for: Antiparkinson Agents
Total 187929 results
-
LobSor Pharmaceuticals ABTFS Trial Form SupportCompleted
-
Shirley Ryan AbilityLabU.S. Department of EducationCompleted
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
University of California, BerkeleyUniversity of California, San Francisco; Lawrence Berkeley National LaboratoryCompletedExecutive Function | Decision Making | DopamineUnited States
-
VA Office of Research and DevelopmentEmory UniversityEnrolling by invitation
-
HaEmek Medical Center, IsraelCompleted
-
Bial - Portela C S.A.CompletedParkinson DiseaseUnited Kingdom
-
Milton S. Hershey Medical CenterPfizerCompleted
-
GlaxoSmithKlineCompletedParkinson DiseaseJapan
-
Boston Children's HospitalCompletedAngelman SyndromeUnited States
-
VeroScienceCompletedType 2 DiabetesUnited States
-
Orion Corporation, Orion PharmaCompleted
-
University Hospital, BonnUnknownSchizophrenia | HyperprolactinemiaGermany
-
CancerCare ManitobaUniversity of Manitoba; Canadian Institutes of Health Research (CIHR); The Metabolomics... and other collaboratorsRecruiting
-
Minia UniversityCompletedOvarian Hyperstimulation SyndromeEgypt
-
University of New MexicoActive, not recruitingChronic Subdural HematomaUnited States
-
Federal University of São PauloNacional Conseling of Scientific Development and TechnologyCompleted
-
Aljazeera HospitalCompleted
-
Emory UniversityNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingParkinson DiseaseUnited States
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingAcute Stroke | Stroke RehabilitationSwitzerland
-
Chelsea TherapeuticsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Jessica M D'AmicoSuspended
-
Ross D. Zafonte, MDWithdrawnStrokeUnited States
-
Eastern Virginia Medical SchoolCompletedDiabetic Autonomic NeuropathyUnited States
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)CompletedAmblyopiaUnited States
-
Somerset PharmaceuticalsCompletedMajor Depressive DisorderUnited States
-
Lupin Ltd.CompletedPharmacokinetic StudyIndia
-
Somerset PharmaceuticalsCompleted
-
Rush University Medical CenterMichael J. Fox Foundation for Parkinson's ResearchCompleted
-
Zhiyi ZuoSun Yat-sen University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownPostoperative Cognitive DysfunctionChina
-
Copenhagen University Hospital, HvidovreUniversity of CopenhagenRecruiting
-
Loewenstein HospitalUnknownTraumatic Brain InjuryIsrael
-
National Institute of Neurological Disorders and...Completed
-
State University of New York - Downstate Medical...ACADIA Pharmaceuticals Inc.Recruiting
-
ACADIA Pharmaceuticals Inc.RecruitingIrritability Associated With Autism Spectrum DisorderUnited States, Spain, France, Australia, Poland, Italy, Serbia, Hungary
-
ACADIA Pharmaceuticals Inc.Active, not recruitingSchizophreniaArgentina, Bulgaria, Croatia, Czechia, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Ukraine
-
Baylor College of MedicineACADIA Pharmaceuticals Inc.WithdrawnPosttraumatic Stress Disorder | Insomnia ChronicUnited States
-
Vanderbilt University Medical CenterCompletedCirrhosis | Muscle CrampUnited States
-
ACADIA Pharmaceuticals Inc.CompletedParkinson Disease PsychosisUnited States
-
ACADIA Pharmaceuticals Inc.CompletedNeuropsychiatric Symptoms Related to Neurodegenerative DiseaseUnited States, Russian Federation, Serbia, Poland, Georgia, Czechia, Bulgaria, Colombia, Mexico, Romania, South Africa, Ukraine
-
ACADIA Pharmaceuticals Inc.CompletedSchizophreniaUnited States, Spain, Hungary, Bulgaria, Russian Federation, Serbia, Ukraine, Poland, Canada, Czechia
-
Boehringer IngelheimCompleted
-
Rajesh Pahwa, MDGlaxoSmithKlineCompleted
-
Baylor College of MedicineNational Institute on Drug Abuse (NIDA)CompletedSubstance Abuse | Cocaine Dependence | Cocaine Abuse | Cocaine AddictionUnited States
-
Forest LaboratoriesCompletedEvaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia PatientsSchizophreniaUnited States
-
Institute for Neurodegenerative DisordersUnited States Department of Defense; Boehringer IngelheimCompletedParkinson Disease | Parkinsonian SyndromeUnited States
-
VA Office of Research and DevelopmentACADIA Pharmaceuticals Inc.RecruitingInsomnia | Post-traumatic Stress DisorderUnited States
-
National Cheng-Kung University HospitalMinistry of Science and Technology, TaiwanRecruitingBipolar II DisorderTaiwan
-
ACADIA Pharmaceuticals Inc.CompletedParkinson's Disease PsychosisUnited States
-
Novartis PharmaceuticalsTerminatedCushings DiseaseItaly, Belgium, India, Netherlands, Argentina, Germany, Turkey, Brazil, Spain, Hungary, Malaysia, Mexico, Greece, United States, Colombia, France